Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 94
Filter
Add more filters

Country/Region as subject
Affiliation country
Publication year range
1.
BMC Med Educ ; 24(1): 191, 2024 Feb 25.
Article in English | MEDLINE | ID: mdl-38403582

ABSTRACT

BACKGROUND: The global outbreak of coronavirus disease (COVID-19) has led medical universities in China to conduct online teaching. This study aimed to assess the effectiveness of a blended learning approach that combines online teaching and virtual reality technology in dental education and to evaluate the acceptance of the blended learning approach among dental teachers and students. METHODS: The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) checklist was followed in this study. A total of 157 students' perspectives on online and virtual reality technology education and 54 teachers' opinions on online teaching were collected via questionnaires. Additionally, 101 students in the 2015-year group received the traditional teaching method (TT group), while 97 students in the 2017-year group received blended learning combining online teaching and virtual reality technology (BL group). The graduation examination results of students in the two groups were compared. RESULTS: The questionnaire results showed that most students were satisfied with the online course and the virtual simulation platform teaching, while teachers held conservative and neutral attitudes toward online teaching. Although the theoretical score of the BL group on the final exam was greater than that of the TT group, there was no significant difference between the two groups (P = 0.805). The skill operation score of the BL group on the final exam was significantly lower than that of the TT group (P = 0.004). The overall score of the BL group was lower than that of the TT group (P = 0.018), but the difference was not statistically significant (P = 0.112). CONCLUSIONS: The blended learning approach combining online teaching and virtual reality technology plays a positive role in students' learning and is useful and effective in dental education.


Subject(s)
Education, Distance , Humans , Cross-Sectional Studies , Education, Distance/methods , Learning , Educational Measurement/methods , Education, Dental/methods
2.
Int Heart J ; 65(3): 498-505, 2024.
Article in English | MEDLINE | ID: mdl-38825494

ABSTRACT

This study aimed to explore the expression of long non-coding RNA (lncRNA) nuclear paraspeckle assembly transcript 1 (NEAT1) in patients with acute myocardial infarction (AMI) and its inflammatory regulation mechanism through miR-211/interleukin 10 (IL-10) axis.A total of 75 participants were enrolled in this study: 25 healthy people in the control group, 25 patients with stable angina pectoris (SAP) in the SAP group, and 25 patients with AMI in the AMI group. Real-time qPCR was used to detect mRNA expression levels of NEAT1, miR-211, and IL-10. The interaction between miR-211, NEAT1, and IL-10 was confirmed by dual-luciferase reporter assay, and protein expression was detected using western blot.High expression of NEAT1 in peripheral blood mononuclear cells (PBMCs) of patients with AMI was negatively related to serum creatine kinase-MB (CK-MB), cardiac troponin I (cTnI), tumor necrosis factor-α (TNF-α), IL-6, and IL-1ß and was positively correlated with left ventricular ejection fraction (LVEF). In THP-1 cells, miR-211 was confirmed to target and inhibit IL-10 expression. NEAT1 knockdown and miR-211-mimic markedly decreased IL-10 protein levels, whereas anti-miR-211 markedly increased IL-10 protein levels. Importantly, miR-211 level was negatively related to NEAT1 and IL-10 levels, whereas IL-10 level was positively related to the level of NEAT1 expression in PBMCs of patients with AMI.LncRNA NEAT1 was highly expressed in PBMCs of patients with AMI, and NEAT1 suppressed inflammation via miR-211/IL-10 axis in PBMCs of patients with AMI.


Subject(s)
Interleukin-10 , Leukocytes, Mononuclear , MicroRNAs , Myocardial Infarction , RNA, Long Noncoding , Humans , RNA, Long Noncoding/genetics , RNA, Long Noncoding/blood , MicroRNAs/blood , MicroRNAs/genetics , Interleukin-10/blood , Interleukin-10/metabolism , Myocardial Infarction/blood , Myocardial Infarction/genetics , Myocardial Infarction/metabolism , Leukocytes, Mononuclear/metabolism , Male , Female , Middle Aged , Aged , Inflammation/genetics , Inflammation/blood , Inflammation/metabolism , Case-Control Studies
3.
J Neurooncol ; 165(1): 149-160, 2023 Oct.
Article in English | MEDLINE | ID: mdl-37897649

ABSTRACT

PURPOSE: The prognosis of patients with leptomeningeal metastasis (LM) remains poor. Circulating tumour DNA (ctDNA) has been proven to be abundantly present in cerebrospinal fluid (CSF); hence, its clinical implication as a biomarker needs to be further verified. METHODS: We conducted a retrospective study of 35 lung adenocarcinoma (LUAD) patients with LM, and matched CSF and plasma samples were collected from all patients. All paired samples underwent next-generation sequencing (NGS) of 139 lung cancer-associated genes. The clinical characteristics and genetic profiling of LM were analysed in association with survival prognosis. RESULTS: LM showed genetic heterogeneity, in which CSF had a higher detection rate of ctDNA (P = 0.003), a higher median mutation count (P < 0.0001), a higher frequency of driver mutations (P < 0.01), and more copy number variation (CNV) alterations (P < 0.001) than plasma. The mutation frequencies of the EGFR, TP53, CDKN2A, MYC and CDKN2B genes were easier to detect in CSF than in LUAD tissue (P < 0.05), possibly reflecting the underlying mechanism of LM metastasis. CSF ctDNA is helpful for analysing the mechanism of EGFR-TKI resistance. In cohort 1, which comprised patients who received 1/2 EGFR-TKIs before the diagnosis of LM, TP53 and CDKN2A were the most common EGFR-independent resistant mutations. In cohort 2, comprising those who progressed after osimertinib and developed LM, 7 patients (43.75%) had EGFR CNV detected in CSF but not plasma. Furthermore, patient characteristics and various genes were included for interactive survival analysis. Patients with EGFR-mutated LUAD (P = 0.042) had a higher median OS, and CSF ctDNA mutation with TERT (P = 0.013) indicated a lower median OS. Last, we reported an LM case in which CSF ctDNA dynamic changes were well correlated with clinical treatment. CONCLUSIONS: CSF ctDNA could provide a more comprehensive genetic landscape of LM, indicating the potential metastasis-related and EGFR-TKI resistance mechanisms of LM patients. In addition, genotyping of CSF combined with clinical outcomes can predict the prognosis of LUAD patients with LM.


Subject(s)
Adenocarcinoma of Lung , Carcinoma, Non-Small-Cell Lung , Circulating Tumor DNA , Lung Neoplasms , Meningeal Carcinomatosis , Humans , Lung Neoplasms/pathology , Circulating Tumor DNA/genetics , Circulating Tumor DNA/cerebrospinal fluid , Carcinoma, Non-Small-Cell Lung/pathology , Retrospective Studies , DNA Copy Number Variations , Genotype , Adenocarcinoma of Lung/genetics , Adenocarcinoma of Lung/pathology , Meningeal Carcinomatosis/genetics , Mutation , ErbB Receptors/genetics , Protein Kinase Inhibitors/therapeutic use
4.
Diabetes Obes Metab ; 25(6): 1714-1722, 2023 06.
Article in English | MEDLINE | ID: mdl-36811214

ABSTRACT

AIM: To assess whether the beta-cell function of inpatients undergoing antidiabetic treatment influences achieving time in range (TIR) and time above range (TAR) targets. MATERIALS AND METHODS: This cross-sectional study included 180 inpatients with type 2 diabetes. TIR and TAR were assessed by a continuous glucose monitoring system, with target achievement defined as TIR more than 70% and TAR less than 25%. Beta-cell function was assessed by the insulin secretion-sensitivity index-2 (ISSI2). RESULTS: Following antidiabetic treatment, logistic regression analysis showed that lower ISSI2 was associated with a decreased number of inpatients achieving TIR (OR = 3.10, 95% CI: 1.19-8.06) and TAR (OR = 3.40, 95% CI: 1.35-8.55) targets after adjusting for potential confounders. Similar associations still existed in those participants treated with insulin secretagogues (TIR: OR = 2.91, 95% CI: 0.90-9.36, P = .07; TAR, OR = 3.14, 95% CI: 1.01-9.80) or adequate insulin therapy (TIR: OR = 2.84, 95% CI: 0.91-8.81, P = .07; TAR, OR = 3.24, 95% CI: 1.08-9.67). Furthermore, receiver operating characteristic curves showed that the diagnostic value of the ISSI2 for achieving TIR and TAR targets was 0.73 (95% CI: 0.66-0.80) and 0.71 (95% CI: 0.63-0.79), respectively. CONCLUSIONS: Beta-cell function was associated with achieving TIR and TAR targets. Stimulating insulin secretion or exogenous insulin treatment could not overcome the disadvantage of lower beta-cell function on glycaemic control.


Subject(s)
Diabetes Mellitus, Type 2 , Humans , Diabetes Mellitus, Type 2/complications , Hypoglycemic Agents/therapeutic use , Blood Glucose Self-Monitoring , Cross-Sectional Studies , Inpatients , Blood Glucose/analysis , Insulin/therapeutic use
5.
Biomarkers ; 28(5): 448-457, 2023 Dec.
Article in English | MEDLINE | ID: mdl-37128800

ABSTRACT

BACKGROUND: Circular RNA (circRNA) CDR1as is emerging as a vital tumour regulator. This study aimed to investigate its diagnostic and prognostic value and molecular mechanisms for gastric cancer (GC). METHODS: CDR1as expression in GC and adjacent normal tissues (n = 82), paired plasma (n = 65) and plasma exosome samples (n = 68) from GC patients and healthy controls were determined by reverse transcription quantitative polymerase chain reaction (RT-qPCR). Correlations between CDR1as level and clinicopathological factors of GC patients were analysed. Its diagnostic and prognostic value was evaluated by receiver operating characteristic (ROC) curves and Cox regression analysis combined with Kaplan-Meier plots. CDR1as-regulated proteins and signalling pathways were identified by quantitative proteomics and bioinformatic analysis. RESULTS: CDR1as was downregulated in GC tissues and associated with tumour size and neural invasion. Plasma- and exosome-derived CDR1as was upregulated in GC patients while plasma-derived CDR1as level was related to lymphatic metastasis. Area under ROC curve (AUC) of tissue-, plasma- and exosome-derived CDR1as was 0.782, 0.641, 0.536 while combination of plasma CDR1as, serum CEA and CA19-9 increased AUC to 0.786. Distal metastasis, TNM stage and tissue-derived CDR1as level were independent predictors for overall survival (OS) of patients. MiRNA signalling networks and glycine, serine and threonine metabolism were regulated by CDR1as and HSPE1 might be a key protein. CONCLUSIONS: CDR1as is a crucial regulator and promising biomarker for GC diagnosis and prognosis.


CDR1as level in tumour tissues and plasma of GC patients was associated with tumour progression. The findings indicate that CDR1as is involved in GC progression and is a potential diagnostic and prognostic biomarker.


Subject(s)
MicroRNAs , Stomach Neoplasms , Humans , RNA, Circular/genetics , Prognosis , Biomarkers, Tumor , Stomach Neoplasms/diagnosis , Stomach Neoplasms/genetics , Stomach Neoplasms/pathology , MicroRNAs/genetics , MicroRNAs/metabolism
6.
Cardiovasc Drugs Ther ; 37(3): 549-560, 2023 06.
Article in English | MEDLINE | ID: mdl-35138505

ABSTRACT

PURPOSE: This study compared the effectiveness of sacubitril/valsartan (SV) vs. valsartan (V) for treating persistent atrial fibrillation (AF) after radio-frequency catheter ablation (RFCA). METHODS: Patients with persistent AF who received RFCA were randomly assigned to the SV or V treatment group with the intervention lasting for 12 months. The primary outcome included any atrial arrhythmia episode lasting ≥ 30 s after a 3-month blanking period. The secondary outcome included any atrial arrhythmia episode lasting ≥ 24 h or requiring cardioversion after a 3-month blanking period. The H2FPEF score was used to assess the possibility of patients suffering from heart failure with preserved ejection fraction. RESULTS: A total of 143 patients with persistent AF who received RFCA were randomized for the study, with 5 patients failing to follow-up. Among them, 29 (42%) out of 69 patients receiving V and 15 (21.7%) out of 69 patients receiving SV reached the primary endpoint (P < 0.001). A total of 26 (37.7%) out of 69 patients receiving V and 7 (10.1%) out of 69 patients receiving SV reached the secondary endpoint (P < 0.001). A decrease in the H2FPEF score after a 1-year follow-up seemed to be related to the recurrence of AF (OR, 0.065; 95% CI: 0.018-0.238, P < 0.001). CONCLUSIONS: SV can decrease AF recurrence after catheter ablation in patients with persistent AF at the 1-year follow-up. The mechanism for this process may be related to the reduction in the H2FPEF score in patients with preserved ejection fraction heart failure.


Subject(s)
Atrial Fibrillation , Catheter Ablation , Heart Failure , Humans , Atrial Fibrillation/diagnosis , Atrial Fibrillation/drug therapy , Atrial Fibrillation/surgery , Recurrence , Catheter Ablation/adverse effects , Heart Failure/diagnosis , Heart Failure/therapy , Valsartan/adverse effects , Treatment Outcome
7.
Neuromodulation ; 26(1): 57-67, 2023 Jan.
Article in English | MEDLINE | ID: mdl-35088742

ABSTRACT

OBJECTIVES: Spinal cord stimulation (SCS) is an established neuromodulation method that regulates the cardiac autonomic system. However, the biological mechanisms of the therapeutic effects of SCS after myocardial infarction (MI) remain unclear. MATERIALS AND METHODS: Twenty-five rabbits were divided into five groups: SCS-MI (voltage: 0.5 v; pulse width: 0.2 ms; 50 Hz; ten minutes on and 30 minutes off; two weeks; n = 5), MI (n = 5), sham SCS-MI (voltage: 0 v; two weeks; n = 5), sham MI (n = 5), and blank control (n = 5) groups. MI was induced by permanent left anterior descending artery ligation. SCS-MI and sham SCS-MI rabbits received the corresponding interventions 24 hours after MI. Autonomic remodeling was evaluated using enzyme-linked immunosorbent assay and immunohistochemistry. Inflammation and myocardial fibrosis were assessed using immunohistochemistry, quantitative polymerase chain reaction, hematoxylin and eosin staining, Masson staining, and Western blot. RESULTS: SCS improved the abnormal systemic autonomic activity. Cardiac norepinephrine decreased after MI (p < 0.01) and did not improve with SCS. Cardiac acetylcholine increased with SCS compared with the MI group (p < 0.05). However, no difference was observed between the MI and blank control groups. Growth-associated protein 43 (p < 0.001) and tyrosine hydroxylase (p < 0.001) increased whereas choline acetyltransferase (p < 0.05) decreased in the MI group compared with the blank control group. These changes were attenuated with SCS. SCS inhibited inflammation, decreased the ratio of phosphorylated-Erk to Erk (p < 0.001), and increased the ratio of phosphorylated-STAT3 to STAT3 (p < 0.001) compared with the MI group. Myocardial fibrosis was also attenuated by SCS. CONCLUSIONS: SCS improved abnormal autonomic activity after MI, leading to reduced inflammation, reactivation of STAT3, and inhibition of Erk. Additionally, SCS attenuated myocardial fibrosis. Our results warrant future studies of biological mechanisms of the therapeutic effects of SCS after MI.


Subject(s)
Myocardial Infarction , Spinal Cord Stimulation , Animals , Rabbits , Disease Models, Animal , Fibrosis , Inflammation/therapy , Myocardial Infarction/drug therapy , Spinal Cord Stimulation/methods
8.
J Obstet Gynaecol ; 43(2): 2287125, 2023 Dec.
Article in English | MEDLINE | ID: mdl-38069630

ABSTRACT

BACKGROUND: This study aimed to evaluate the value of non-invasive prenatal testing (NIPT) in the prenatal screening of foetal aneuploidy-associated diseases at different gestational ages. METHODS: Briefly, cell-free foetal DNAs were extracted from plasma first, followed by DNA sequencing and bioinformatics analyses for chromosome aneuploidy (T21, T18, and T13), sex chromosome aneuploidy (SCA), and microdeletion/microduplication. Subsequently, the positive results were subject to karyotype analyses. RESULTS: The pregnant women included in this study were divided into six groups, and the results, such as chromosome diagnoses, and clinical phenotypes, were collected for data analyses. According to the results of the data analysis, the positivity rates of foetal chromosomal abnormalities in pregnant women under 20, 20-24, 25-29, 30-34, 35-39, and >40 years old were 0%, 0.17%, 0.25%, 0.27%, 0.60%, and 1.66%, respectively. The positive predictive value (PPV) in the 20-24 years group was 41.67%, that in the 25-29 years group was 62.5%, that in the 30-34 years group was 66.67%, that in the 35-39 years group was 90.74%, and that in the >40 years group was 90.32%. CONCLUSION: Overall, NIPT detection in elderly pregnant women has excellent clinical application value in reducing the incidence of either birth defects or abortion caused by invasive chromosome examination.


It is critical to diagnose foetal chromosome aneuploidy in time through prenatal screening to prevent birth defects. This study aimed to evaluate the value of non-invasive prenatal testing (NIPT) in prenatal screening of foetal aneuploidy-associated diseases at different gestational ages. A retrospective analysis based on NIPT screening data at a medical laboratory was performed. The results showed that the total positivity rate and total positive predictive value of trisomy 21, trisomy 18, and trisomy 13 in older pregnant women (≥35 years old) were significantly higher than those in younger pregnant women, and there was an increasing trend with increasing maternal ages. This study indicated that NIPT detection in elderly pregnant women has an excellent application value in clinical practice to reduce the incidence of birth defects and abortion caused by invasive chromosome examination.


Subject(s)
Fetal Diseases , Prenatal Diagnosis , Pregnancy , Female , Humans , Aged , Adult , Maternal Age , Prenatal Diagnosis/methods , Aneuploidy , Chromosome Aberrations , Fetal Diseases/diagnosis , Karyotype , Trisomy
9.
Mol Cancer ; 21(1): 141, 2022 07 02.
Article in English | MEDLINE | ID: mdl-35780119

ABSTRACT

BACKGROUND: Increasing studies suggest that circular RNAs (circRNAs) are critical regulators of cancer development and progression. However, the biological roles and mechanisms of circRNAs in gastric cancer (GC) remain largely unknown. METHODS: We identified the differentially expressed circRNAs in GC by analyzing Gene Expression Omnibus (GEO) datasets. We explored the biological roles of circRNAs in GC by in vitro functional assays and in vivo animal studies. We performed tagged RNA affinity purification (TRAP), RNA immunoprecipitation (RIP), mass spectrometry (MS), RNA sequencing, luciferase reporter assays, and rescue experiments to investigate the mechanism of circRNAs in GC. RESULTS: Downregulated expression of circular RNA EIF4G3 (circEIF4G3; hsa_circ_0007991) was found in GC and was associated with poor clinical outcomes. Overexpression of circEIF4G3 suppressed GC growth and metastasis through the inhibition of ß-catenin signaling, whereas knockdown of circEIF4G3 showed the opposite effects. Mechanistic studies revealed that circEIF4G3 bound to δ-catenin protein to promote its TRIM25-mediated ubiquitin degradation and interacted with miR-4449 to upregulate SIK1 expression. CONCLUSION: Our findings uncovered a tumor suppressor function of circEIF4G3 in GC through the regulation of δ-catenin protein stability and miR-4449/SIK1 axis. CircEIF4G3 may act as a promising prognostic biomarker and therapeutic target for GC.


Subject(s)
MicroRNAs , Stomach Neoplasms , Animals , Catenins , Cell Line, Tumor , Cell Proliferation/genetics , MicroRNAs/genetics , MicroRNAs/metabolism , RNA, Circular/genetics , Stomach Neoplasms/pathology , Ubiquitin , beta Catenin/genetics , Delta Catenin
10.
J Transl Med ; 20(1): 326, 2022 07 21.
Article in English | MEDLINE | ID: mdl-35864511

ABSTRACT

BACKGROUND: Our previous study has identified a novel circRNA (circDIDO1) that is down-regulated in gastric cancer (GC) and significantly inhibits GC progression. The purpose of this study is to identify the molecular mechanism for circDIDO1 and to evaluate the therapeutic effect of circDIDO1 in GC. METHODS: By combining bioinformatic analysis with RNA sequencing data, we predicted the potential target of circDIDO1 and further validated the regulatory mechanisms for its tumor suppressor function in GC. RIP assay, luciferase reporter assay and in vitro cell function assays were performed to analyze circDIDO1-regulated downstream target genes. For the therapeutic study, circDIDO1-loaded, RGD-modified exosomes (RGD-Exo-circDIDO1) were constructed and its anti-tumor efficacy and biological safety were evaluated in vitro and in vivo. RESULTS: CircDIDO1 inhibited GC progression by regulating the expression of the signal transducer inhibitor SOSC2 through sponging miR-1307-3p. Overexpression of circDIDO1 or SOSC2 antagonized the oncogenic role of miR-1307-3p. RGD-Exo-circDIDO1 could efficiently deliver circDIDO1 to increase SOCS2 expression in GC cells. Compared with PBS and RGD-Exo-vector treatment, RGD-Exo-circDIDO1 treatment significantly inhibited the proliferation, migration and invasion of GC cells while promoted cell apoptosis. The therapeutic efficacy of RGD-Exo-circDIDO1 was further confirmed in a mouse xenograft tumor model. In addition, major tissues including the heart, liver, spleen, lungs and kidneys showed no obvious histopathological abnormalities or lesions in the RGD-Exo-circDIDO1 treated group. CONCLUSION: Our findings revealed that circDIDO1 suppressed the progression of GC via modulating the miR-1307-3p/SOSC2 axis. Systemic administration of RGD modified, circDIDO1 loaded exosomes repressed the tumorigenicity and aggressiveness of GC both in vitro and in vivo, suggesting that RGD-Exo-circDIDO1 could be used as a feasible nanomedicine for GC therapy.


Subject(s)
Exosomes , MicroRNAs , Stomach Neoplasms , Animals , Cell Line, Tumor , Cell Proliferation/genetics , Exosomes/metabolism , Gene Expression Regulation, Neoplastic , Humans , Mice , MicroRNAs/genetics , MicroRNAs/metabolism , Oligopeptides , Stomach Neoplasms/pathology , Suppressor of Cytokine Signaling Proteins/genetics , Suppressor of Cytokine Signaling Proteins/metabolism
11.
Cardiovasc Diabetol ; 21(1): 283, 2022 12 19.
Article in English | MEDLINE | ID: mdl-36536433

ABSTRACT

BACKGROUND: Patients with type 2 diabetes mellitus (T2DM) usually have higher blood viscosity attributed to high blood glucose that can decrease blood supply to the pancreas. A mild increase in blood pressure (BP) has been reported as a potential compensatory response that can maintain blood perfusion in the islet. However, how BP influences beta-cell function in T2DM subjects remains inconsistent. This study aimed to examine the relationship between BP and beta-cell function in patients with T2DM under different HbA1c levels. METHODS: This is a cross-sectional study of 615 T2DM patients, whose clinical data were extracted from hospital medical records. Beta-cell function was assessed by insulin secretion-sensitivity index-2 (ISSI2). Multivariable linear regression analysis and restricted cubic splines (RCS) analysis were performed to identify the association between systolic BP (SBP) and ISSI2. Mediation analysis was performed to determine whether higher SBP could reduce blood glucose by enhancing beta-cell function. RESULTS: After adjustment of potential confounders, in participants with HbA1c ≥ 10%, the SBP between 140 to150 mmHg had the highest log ISSI2 (b = 0.227, 95% CI 0.053-0.402), an association specific to participants with < 1 year duration of diabetes. RCS analyses demonstrated an inverted U-shaped association between SBP and ISSI2 with the SBP at 144 mmHg corresponding to the best beta-cell function. This higher SBP was "paradoxically" associated with lower 2 h postprandial blood glucose (PBG) when SBP < 150 mmHg that was almost exclusively mediated by ISSI2 (mediating effect = - 0.043, 95%CI - 0.067 to - 0.018; mediating effect percentage = 94.7%, P < 0.01). SBP was however not associated with improvement in ISSI2 or 2 h PBG in participants with HbA1c < 10%. CONCLUSIONS: In early stage of diabetes, a slightly elevated SBP (140-150 mmHg) was transiently associated with better beta-cell function in T2DM patients with HbA1c ≥ 10% but not in those with HbA1c < 10%.


Subject(s)
Diabetes Mellitus, Type 2 , Humans , Blood Glucose/analysis , Blood Pressure , Glycated Hemoglobin , Cross-Sectional Studies
12.
Ecol Appl ; : e2740, 2022 Sep 14.
Article in English | MEDLINE | ID: mdl-36102220

ABSTRACT

Plant invasions profoundly impact both natural and managed ecosystems, and removal of the invasive plants addresses only part of the problem of restoring impacted areas. The rehabilitation of diverse communities and their ecosystem functions following removal of invasive plants is an important goal of ecological restoration. Arthropod assemblages and trophic interactions are important indicators of the success of restoration, but they have largely been overlooked in saltmarshes. We determined how arthropod assemblages and trophic interactions changed with the invasion of the exotic plant Spartina alterniflora and with the restoration of the native plant Phragmites australis following Spartina removal in a Chinese saltmarsh. We investigated multiple biotic and abiotic variables to gain insight into the factors underlying the changes in arthropod assemblages and trophic structure. We found that although Spartina invasion had changed arthropod diversity, community structure, feeding-guild composition, and the diets of arthropod natural enemies in the saltmarsh, these changes could be reversed by the restoration of native Phragmites vegetation following removal of the invader. The variation in arthropod assemblages and trophic structure were critically associated with four biotic and abiotic variables (aboveground biomass, plant density, leaf N, and soil salinity). Our findings demonstrate the positive effects of controlling invasive plants on biodiversity and nutrient cycling and provide a foundation for assessing the efficacy of ecological restoration projects in saltmarshes.

13.
BMC Endocr Disord ; 22(1): 294, 2022 Nov 26.
Article in English | MEDLINE | ID: mdl-36435767

ABSTRACT

AIMS: To explore facilitators and barriers to self-management engagement of Chinese people with poorly controlled type 2 diabetes. METHODS: Purposive sampling method was used for recruitment. Semi-structured interview and thematic analysis was used for data collection and analysis. RESULTS: Twenty-six semi-structured interviews were conducted. Poor blood glucose control introduced awareness of susceptibility to complications, while mental disorders could be concomitant. General knowledge about healthy lifestyle and unhealthy habits impeded lifestyle management. Temporary remission of hyperglycemia and no perceived symptoms interfered engagement of medication therapy and regular blood glucose monitoring. Family and work environments could impact self-management engagement. Accessibility to reliable diabetes-related information influenced self-management engagement. CONCLUSIONS: Awareness of susceptibility to complications motivated self-management engagement, while the awareness could cause mental disorders that need to be addressed. Customized lifestyle plans and behavior change technologies were crucial for lifestyle management. The progression of diabetes, importance of continuity of medication therapy, and the value of blood glucose monitoring should be clarified in diabetes education. Building diabetes-friendly social environments and providing reliable diabetes-related information were essential.


Subject(s)
Diabetes Mellitus, Type 2 , Self-Management , Humans , Blood Glucose , Diabetes Mellitus, Type 2/therapy , Blood Glucose Self-Monitoring , China/epidemiology
14.
Appl Opt ; 61(11): 3150-3155, 2022 Apr 10.
Article in English | MEDLINE | ID: mdl-35471292

ABSTRACT

Frequency scanning interferometry using state-of-the-art high-speed frequency-swept laser source can be utilized to measure absolute distance on the order of micrometers to centimeters. Current distance demodulation methods based on fast Fourier transform (FFT) or fringe counting cannot achieve satisfactory accuracy when the number of sampling points within a frequency-sweeping period is small; the conventional Hilbert transform is more accurate, but it needs arctangent calculation and phase unwrapping, which is time consuming. So we propose a fast algorithm based on the conventional Hilbert transform to recover the distance from the interference signal. The algorithm is implemented by first performing a Hilbert transform and then solving the phase and the distance from the Hilbert signal with a novel, to the best of our knowledge, method that eliminates the need for arctangent calculation and phase unwrapping. The whole process took only 40 µs, and it is almost 2 times faster than the conventional Hilbert algorithm with little accuracy lost. Simulation results demonstrate that the proposed algorithm is more accurate than the FFT algorithm, and it achieved a standard deviation of 0.062 µm, which was less than that of the FFT, in our experiment at a distance of approximately 16 mm and measurement speed of 1 kHz.

15.
J Acoust Soc Am ; 151(6): 3758, 2022 06.
Article in English | MEDLINE | ID: mdl-35778203

ABSTRACT

Bionic signal waveform design plays an important role in biological research, as well as bionic underwater acoustic detection and communication. Most conventional methods cannot construct high-similarity bionic waveforms to match complex cetacean sounds or easily modify the time-frequency structure of the synthesized bionic signals. In our previous work, we proposed a synthesis and modification method for cetacean tonal sounds, but it requires a lot of manpower to construct each bionic signal segment to match the tonal sound contour. To solve these problems, an automated piecewise synthesis method is proposed. First, based on the time-frequency spectrogram of each tonal sound, the fundamental contour and each harmonic contour of the tonal sound is automatically recognized and extracted. Then, based on the extracted contours, four sub power frequency modulation bionic signal models are combined to match cetacean sound contours. Finally, combining the envelopes of the fundamental frequency and each harmonic, the synthesized bionic signal is obtained. Experimental results show that the Pearson correlation coefficient (PCC) between all true cetacean sounds and their corresponding bionic signals are higher than 0.95, demonstrating that the proposed method can automatically imitate all kinds of simple and complex cetacean tonal sounds with high similarity.


Subject(s)
Sound , Vocalization, Animal , Animals , Cetacea , Sound Spectrography
16.
J Acoust Soc Am ; 152(1): 491, 2022 07.
Article in English | MEDLINE | ID: mdl-35931545

ABSTRACT

Bionic camouflage covert underwater acoustic communication has recently attracted great attention. However, we have not found relevant methods or literature to recognize these bionic camouflage communication signals (BCCSs) in the area of anti-reconnaissance. Focused on recognizing the BCCSs, this article proposes a recognition method based on the statistics of inter-click intervals to recognize the camouflaged click communication train (CCCT), which is modulated by time delay difference (TDD). We first analyze the characteristics of TDD distributions of CCCT and real click train (RCT). According to the coding principle, the TDDs of CCCTs present a ladder-like distribution with a fixed time step, and the TDDs are equal to the integral multiple of the fixed time step. On the contrary, the TDDs of RCTs are approximately random distribution within a certain time range. Therefore, based on the different TDD distributions, this article classifies CCCTs and RCTs by utilizing the statistical property of TDD distributions. To measure the TDDs of diverse cetacean clicks accurately, a new click location scheme based on the dynamic window energy ratio is proposed. Next, based on the statistics of TDD distribution, the influences of the TDDs that are caused by multipath interferences are eliminated by iteration. Simulations demonstrate the accuracy of the recognition method under different conditions.


Subject(s)
Acoustics , Bionics , Acoustic Stimulation/methods , Attention , Communication
17.
Mol Cancer ; 20(1): 101, 2021 08 12.
Article in English | MEDLINE | ID: mdl-34384442

ABSTRACT

BACKGROUND: Circular RNAs (circRNAs) play important roles in cancer development and progression. The purpose of this study is to identify aberrantly expressed circRNAs in gastric cancer (GC), unravel their roles in GC progression, and provide new targets for GC diagnosis and therapy. METHODS: Bioinformatic analyses were performed to identify the aberrantly expression of hsa_circ_0061137 (termed as circDIDO1) in GC. Gain- and loss-of-function studies were performed to examine the biological roles of circDIDO1 in GC progression. Tagged RNA affinity purification, mass spectrometry, immunofluorescence, co-immunoprecipitation, and Western blot were used to identify circRNA-interacting and circRNA-encoded proteins. RNA sequencing, qRT-PCR, and Western blot were performed to analyze circRNA-regulated downstream target genes and signaling pathways. Mouse tumor models were used to analyze the effects of circDIDO1 on GC growth and metastasis. RESULTS: CircDIDO1 was transcribed from human DIDO1 (death-inducer obliterator 1) gene and formed by back-splicing of exons 2-6 of the linear transcript. circDIDO1 was down-regulated in GC tissues and its low levels were associated with larger tumor size, distal metastasis, and poor prognosis. CircDIDO1 overexpression inhibited while knockdown promoted GC cell proliferation, migration and invasion. CircDIDO1 overexpression suppressed GC growth and metastasis in mouse tumor models. Mechanistically, circDIDO1 encoded a novel 529aa protein that directly interacted with poly ADP-ribose polymerase 1 (PARP1) and inhibited its activity. CircDIDO1 also specifically bound to peroxiredoxin 2 (PRDX2) and promoted RBX1-mediated ubiquitination and degradation of PRDX2, which led to the inactivation of its downstream signaling pathways. CONCLUSIONS: CircDIDO1 is a new circRNA that has tumor suppressor function in GC and it may serve as a potential prognostic biomarker and therapeutic target for GC.


Subject(s)
DNA-Binding Proteins/genetics , DNA-Binding Proteins/metabolism , Gene Expression Regulation, Neoplastic , Peroxiredoxins/metabolism , RNA, Circular/genetics , Stomach Neoplasms/metabolism , Animals , Cell Line, Tumor , DNA-Binding Proteins/chemistry , Disease Models, Animal , Gene Expression Profiling , Genes, Tumor Suppressor , Heterografts , Humans , Immunohistochemistry , Mice , Models, Biological , Peroxiredoxins/chemistry , Poly (ADP-Ribose) Polymerase-1/metabolism , Protein Binding , Protein Stability , Proteomics/methods , Signal Transduction , Stomach Neoplasms/genetics , Stomach Neoplasms/pathology
18.
Cell Mol Life Sci ; 77(9): 1661-1680, 2020 May.
Article in English | MEDLINE | ID: mdl-31659415

ABSTRACT

In recent years, a large number of circRNAs have been identified in mammalian cells with high-throughput sequencing technologies and bioinformatics. The aberrant expression of circRNAs has been reported in many human diseases including gastric cancer (GC). The number of GC-related circRNAs with validated biological functions and mechanisms of action is growing. CircRNAs are critically involved in GC cell proliferation, apoptosis, migration, and invasion. CircRNAs have been shown to function as regulators of parental gene transcription and alternative splicing and miRNA sponges. Moreover, circRNAs have been suggested to interact with proteins to regulate their expression level and activities. Several circRNAs have been identified to encode functional proteins. Due to their great abundance, high stability, tissue- and developmental-stage-specific expression patterns, and wide distribution in various body fluids and exosomes, circRNAs exhibit a great potential to be utilized as biomarkers for GC. Herein, we briefly summarize their biogenesis, properties and biological functions and discuss about the current research progress of circRNAs in GC with a focus on the potential application for GC diagnosis and therapy.


Subject(s)
Biomarkers/analysis , RNA, Circular/genetics , Stomach Neoplasms/diagnosis , Stomach Neoplasms/therapy , Animals , Humans , Stomach Neoplasms/genetics
19.
Appl Opt ; 60(19): 5507-5516, 2021 Jul 01.
Article in English | MEDLINE | ID: mdl-34263837

ABSTRACT

In conventional dual-projection moiré topography, the additive-type moiré pattern has an amplitude modulated form, and therefore poor visibility, unable to be improved through low-pass filtering. To overcome this difficulty, this paper presents an enhanced dual-projection moiré topography by means of logical moiré. In its implementation, a couple of projectors project two fringe patterns of different colors onto the object simultaneously and then a color camera captures the deformed fringe pattern. Instead of directly processing the additive-type moiré fringes, we separate the deformed fringes of two chromatic channels, binarize them, and then calculate their exclusive OR (XOR) moiré pattern. By differentiating one of the two deformed fringe patterns, a second XOR moiré pattern having exactly a π/2-rad phase shift can also be generated, so that the phases are simply calculated by using an arctangent function after low-pass filtering to the XOR moiré patterns. By doing so, we can measure the three-dimensional shape of an object in an efficient way requiring a single-shot implementation. The validity of this method has been demonstrated through simulation and experimental results.

20.
Sensors (Basel) ; 20(6)2020 Mar 11.
Article in English | MEDLINE | ID: mdl-32168887

ABSTRACT

Metallic surface defect detection is an essential and necessary process to control the qualities of industrial products. However, due to the limited data scale and defect categories, existing defect datasets are generally unavailable for the deployment of the detection model. To address this problem, we contribute a new dataset called GC10-DET for large-scale metallic surface defect detection. The GC10-DET dataset has great challenges on defect categories, image number, and data scale. Besides, traditional detection approaches are poor in both efficiency and accuracy for the complex real-world environment. Thus, we also propose a novel end-to-end defect detection network (EDDN) based on the Single Shot MultiBox Detector. The EDDN model can deal with defects with different scales. Furthermore, a hard negative mining method is designed to alleviate the problem of data imbalance, while some data augmentation methods are adopted to enrich the training data for the expensive data collection problem. Finally, the extensive experiments on two datasets demonstrate that the proposed method is robust and can meet accuracy requirements for metallic defect detection.

SELECTION OF CITATIONS
SEARCH DETAIL